drugset / Trial / NCT02233985

Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

NCT02233985 ↗

Phase 4 Completed 64 enrolled Coordinación de Investigación en Salud, Mexico
RandomizedParallel-groupQuadruple-blindTreatment

Summary

\- Determine the efficacy of nebulized salbutamol/hypertonic saline combination in moderate to severe bronchiolitis.

Timeline

Start
2013-08
Primary completion
2017-03
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 0.9 % Inhaled
Subject sodium chloride Unknown 3 % Inhaled

Indications